Maj Invest UCITS Etf Lifestyle & Obesity (CPH:MAJLO)
109.25
+0.90 (0.83%)
At close: Dec 5, 2025
4.10% (1Y)
| Assets | n/a |
| Expense Ratio | n/a |
| PE Ratio | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +4.10% |
| Volume | 17,161 |
| Open | 109.35 |
| Previous Close | 108.35 |
| Day's Range | 109.00 - 109.35 |
| 52-Week Low | 85.92 |
| 52-Week High | 111.10 |
| Beta | n/a |
| Holdings | 42 |
| Inception Date | Nov 18, 2024 |
About MAJLO
MAJLO.CO was created on 2024-11-18 by Maj Invest. The fund's investment portfolio concentrates primarily on health care equity. Der er ikke nogen lbetid p produktet. Beslutning om afvikling af foreningen, en afdeling eller en andelsklasse kan trffes af henholdsvis foreningens generalforsamling eller en afdelings eller en andelsklasses investorer
Asset Class Equity
Category Health Care
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol MAJLO
Provider Maj Invest
Performance
MAJLO had a total return of 4.10% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.56%.
Top 10 Holdings
43.50% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 4.67% |
| Pfizer Inc. | PFE | 4.53% |
| Johnson & Johnson | JNJ | 4.49% |
| Merck & Co., Inc. | MRK | 4.49% |
| Novartis AG | NOVN | 4.46% |
| AstraZeneca PLC | AZN | 4.45% |
| Roche Holding AG | ROG | 4.37% |
| Novo Nordisk A/S | NOVO.B | 4.34% |
| Takeda Pharmaceutical Company Limited | 4502 | 4.30% |
| Intuitive Surgical, Inc. | ISRG | 3.38% |